E-Z-EM stockholders approve Bracco Diagnostics merger

E-Z-EM  announced today that its stockholders voted to approve the merger agreement providing for the acquisition of the company by Bracco Diagnostics, the U.S. subsidiary of Bracco Imaging S.p.A, at a special meeting of the stockholders held Thursday in Garden City, N.Y.

The number of shares voting to adopt the merger agreement represents approximately 69.1 percent of the total number of shares outstanding and entitled to vote.

The proposed merger, previously announced Oct. 30, 2007, is expected to close on or about April 1, pending the satisfaction or waiver of all the closing conditions set forth in the merger agreement.

Under the terms of the merger agreement, E-Z-EM stockholders will receive $21.00 per share in cash, without interest.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.